Jay Seemann
About Jay Seemann
Jay Seemann is the Global Vice President of Market Access & Value at BeiGene, with extensive experience in commercial functions across multiple global markets.
Title
Jay Seemann is the Global Vice President Market Access & Value: National Accounts, Payers, Pricing, and Distribution at BeiGene.
Company
Jay Seemann is currently employed at BeiGene, serving in the role of Global Vice President Market Access & Value: National Accounts, Payers, Pricing, and Distribution. BeiGene operates in the biopharmaceutical sector, focusing on molecularly targeted and immuno-oncology drug development.
Previous Work Experience
Before BeiGene, Jay Seemann held significant leadership positions at various companies. He was the Global Vice President Commercial Diagnostics at NanoString Technologies, Inc. from 2014 to 2019, where he oversaw sales, marketing, market access, and operations. At Onyx Pharmaceuticals, he served as the Senior Director of US Market Access & Value from 2008 to 2013. Prior to that, he was the Director of Market Access at Bayer Pharmaceuticals and GPC Biotech from 2005 to 2007. Jay also served as the Director of National Accounts at Sanofi Aventis from 2001 to 2006.
Education and Expertise
Jay Seemann has a strong educational background, including executive leadership training from Duke University's Fuqua School of Business and a program from Harvard Business School. He also holds a Bachelor of Science degree from Ball State University's Miller College of Business, where he studied Sales, Distribution, and Marketing Operations.
Global Leadership Experience
Jay Seemann has extensive experience in global market leadership, having worked in the US, EU, Canada, APAC, and Emerging Markets. His roles have involved leading commercial functions across multiple global markets, including distribution, 3PL & network, payer/PBM, value & access, national accounts, patient support, pricing & contracting, and HTA strategy and submissions.
Expertise in Market Preparation
Jay Seemann is known for building first-time commercial capabilities for organizations, preparing them for initial product launches in global markets. This includes developing strategies for distribution, pricing, reimbursement, and access among other commercial functions.